Cargando…
Effect of treatment on the immunological status of women with advanced breast cancer.
An immunological profile has been serially studied in 72 patients with advanced breast cancer during the course of a randomized trial of chemotherapy and hormonal manipulation. DNCB+ patients were more likely to respond to either therapy, but no other test was predictive of response. In the follow-u...
Autores principales: | Webster, D. J., Richardson, G., Baum, M., Priestman, T., Hughes, L. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009985/ https://www.ncbi.nlm.nih.gov/pubmed/444406 |
Ejemplares similares
-
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
por: Johnson, J. R., et al.
Publicado: (1984) -
Stress and breast cancer.
por: Priestman, T. J., et al.
Publicado: (1985) -
Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022) -
Status and prognostic value of immunological biomarkers of breast cancer
por: Murazawa, Chisa, et al.
Publicado: (2023) -
The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast.
por: Canney, P. A., et al.
Publicado: (1988)